Global portfolio Assess opportunities to cross-sell and bundle across Viatris’ diversified portfolio that spans generics, established brands, and innovative medicines to address unmet needs in different markets and payer segments.

FDA approvals Leverage recent FDA approvals such as Gwyn Lo for women’s health to position partnerships around contraception, specialty formulations, and long-acting delivery systems in retail and clinic channels.

Supply resilience Position Viatris as a partner for resilient supply chains to healthcare providers and distributors by emphasizing ongoing manufacturing capabilities and risk mitigation for essential therapies amid regulatory and tariff shifts.

Global footprint Target multinational buyers and health systems by highlighting Viatris’ global centers in the US, Asia, and India to support regional manufacturing, regulatory navigation, and market access strategies.

Healthcare focus Explore partnerships in women’s health, geriatrics, and chronic disease management where Viatris’ mix of generics and innovative medicines can deliver cost-effective, scalable solutions to payers and providers.